ArticleBlood cancer journal2025

Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.

Vinod Pullarkat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.